title: Adverse events after imatinib mesylate therapy.
authors.forename: Catherine
authors.initials: C
authors.lastname: Burton
authors.forename: Anthony
authors.initials: A
authors.lastname: Azzi
authors.forename: Ian
authors.initials: I
authors.lastname: Kerridge
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D001853:Bone Marrow / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008297:Male; D009336:Necrosis; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate